Global and Japan Antibody-drug Conjugate Market Insights, Forecast to 2026

Publisher Name :
Date: 24-Nov-2020
No. of pages: 130
Inquire Before Buying

Antibody-drug Conjugate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antibody-drug Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Antibody-drug Conjugate market is segmented into

- Adcetris

- Kadcyla

Segment by Application, the Antibody-drug Conjugate market is segmented into

- Breast Cancer

- Lymphoma

Regional and Country-level Analysis

The Antibody-drug Conjugate market is analysed and market size information is provided by regions (countries).

The key regions covered in the Antibody-drug Conjugate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Antibody-drug Conjugate Market Share Analysis

Antibody-drug Conjugate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody-drug Conjugate business, the date to enter into the Antibody-drug Conjugate market, Antibody-drug Conjugate product introduction, recent developments, etc.

The major vendors covered:

- Agensys

- Concortis Biotherapeutics

- Sanofi

- Celldex Therapeutics

- Synthon Holding BV

- ...

Global and Japan Antibody-drug Conjugate Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antibody-drug Conjugate Product Introduction
1.2 Market Segments
1.3 Key Antibody-drug Conjugate Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibody-drug Conjugate Market Size Growth Rate by Type
1.4.2 Adcetris
1.4.3 Kadcyla
1.5 Market by Application
1.5.1 Global Antibody-drug Conjugate Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibody-drug Conjugate Market Size, Estimates and Forecasts
2.1.1 Global Antibody-drug Conjugate Revenue 2015-2026
2.1.2 Global Antibody-drug Conjugate Sales 2015-2026
2.2 Global Antibody-drug Conjugate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Antibody-drug Conjugate Historical Market Size by Region (2015-2020)
2.3.1 Global Antibody-drug Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Antibody-drug Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Antibody-drug Conjugate Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Antibody-drug Conjugate Sales Forecast by Region (2021-2026)
2.4.2 Global Antibody-drug Conjugate Revenue Forecast by Region (2021-2026)
3 Global Antibody-drug Conjugate Competitor Landscape by Players
3.1 Global Top Antibody-drug Conjugate Sales by Manufacturers
3.1.1 Global Antibody-drug Conjugate Sales by Manufacturers (2015-2020)
3.1.2 Global Antibody-drug Conjugate Sales Market Share by Manufacturers (2015-2020)
3.2 Global Antibody-drug Conjugate Manufacturers by Revenue
3.2.1 Global Antibody-drug Conjugate Revenue by Manufacturers (2015-2020)
3.2.2 Global Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody-drug Conjugate Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibody-drug Conjugate Revenue in 2019
3.2.5 Global Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antibody-drug Conjugate Price by Manufacturers
3.4 Global Antibody-drug Conjugate Manufacturing Base Distribution, Product Types
3.4.1 Antibody-drug Conjugate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody-drug Conjugate Product Type
3.4.3 Date of International Manufacturers Enter into Antibody-drug Conjugate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antibody-drug Conjugate Market Size by Type (2015-2020)
4.1.1 Global Antibody-drug Conjugate Sales by Type (2015-2020)
4.1.2 Global Antibody-drug Conjugate Revenue by Type (2015-2020)
4.1.3 Antibody-drug Conjugate Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibody-drug Conjugate Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibody-drug Conjugate Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody-drug Conjugate Revenue Forecast by Type (2021-2026)
4.2.3 Antibody-drug Conjugate Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibody-drug Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antibody-drug Conjugate Market Size by Application (2015-2020)
5.1.1 Global Antibody-drug Conjugate Sales by Application (2015-2020)
5.1.2 Global Antibody-drug Conjugate Revenue by Application (2015-2020)
5.1.3 Antibody-drug Conjugate Price by Application (2015-2020)
5.2 Antibody-drug Conjugate Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibody-drug Conjugate Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody-drug Conjugate Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody-drug Conjugate Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Antibody-drug Conjugate Market Size YoY Growth 2015-2026
6.1.1 Japan Antibody-drug Conjugate Sales YoY Growth 2015-2026
6.1.2 Japan Antibody-drug Conjugate Revenue YoY Growth 2015-2026
6.1.3 Japan Antibody-drug Conjugate Market Share in Global Market 2015-2026
6.2 Japan Antibody-drug Conjugate Market Size by Players (International and Local Players)
6.2.1 Japan Top Antibody-drug Conjugate Players by Sales (2015-2020)
6.2.2 Japan Top Antibody-drug Conjugate Players by Revenue (2015-2020)
6.3 Japan Antibody-drug Conjugate Historic Market Review by Type (2015-2020)
6.3.1 Japan Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
6.3.2 Japan Antibody-drug Conjugate Revenue Market Share by Type (2015-2020)
6.3.3 Japan Antibody-drug Conjugate Price by Type (2015-2020)
6.4 Japan Antibody-drug Conjugate Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Antibody-drug Conjugate Sales Forecast by Type (2021-2026)
6.4.2 Japan Antibody-drug Conjugate Revenue Forecast by Type (2021-2026)
6.4.3 Japan Antibody-drug Conjugate Price Forecast by Type (2021-2026)
6.5 Japan Antibody-drug Conjugate Historic Market Review by Application (2015-2020)
6.5.1 Japan Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
6.5.2 Japan Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
6.5.3 Japan Antibody-drug Conjugate Price by Application (2015-2020)
6.6 Japan Antibody-drug Conjugate Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Antibody-drug Conjugate Sales Forecast by Application (2021-2026)
6.6.2 Japan Antibody-drug Conjugate Revenue Forecast by Application (2021-2026)
6.6.3 Japan Antibody-drug Conjugate Price Forecast by Application (2021-2026)
7 North America
7.1 North America Antibody-drug Conjugate Market Size YoY Growth 2015-2026
7.2 North America Antibody-drug Conjugate Market Facts & Figures by Country
7.2.1 North America Antibody-drug Conjugate Sales by Country (2015-2020)
7.2.2 North America Antibody-drug Conjugate Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Antibody-drug Conjugate Market Size YoY Growth 2015-2026
8.2 Europe Antibody-drug Conjugate Market Facts & Figures by Country
8.2.1 Europe Antibody-drug Conjugate Sales by Country
8.2.2 Europe Antibody-drug Conjugate Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antibody-drug Conjugate Market Size YoY Growth 2015-2026
9.2 Asia Pacific Antibody-drug Conjugate Market Facts & Figures by Country
9.2.1 Asia Pacific Antibody-drug Conjugate Sales by Region (2015-2020)
9.2.2 Asia Pacific Antibody-drug Conjugate Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Antibody-drug Conjugate Market Size YoY Growth 2015-2026
10.2 Latin America Antibody-drug Conjugate Market Facts & Figures by Country
10.2.1 Latin America Antibody-drug Conjugate Sales by Country
10.2.2 Latin America Antibody-drug Conjugate Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antibody-drug Conjugate Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Antibody-drug Conjugate Market Facts & Figures by Country
11.2.1 Middle East and Africa Antibody-drug Conjugate Sales by Country
11.2.2 Middle East and Africa Antibody-drug Conjugate Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Agensys
12.1.1 Agensys Corporation Information
12.1.2 Agensys Description and Business Overview
12.1.3 Agensys Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Agensys Antibody-drug Conjugate Products Offered
12.1.5 Agensys Recent Development
12.2 Concortis Biotherapeutics
12.2.1 Concortis Biotherapeutics Corporation Information
12.2.2 Concortis Biotherapeutics Description and Business Overview
12.2.3 Concortis Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Concortis Biotherapeutics Antibody-drug Conjugate Products Offered
12.2.5 Concortis Biotherapeutics Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Description and Business Overview
12.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Antibody-drug Conjugate Products Offered
12.3.5 Sanofi Recent Development
12.4 Celldex Therapeutics
12.4.1 Celldex Therapeutics Corporation Information
12.4.2 Celldex Therapeutics Description and Business Overview
12.4.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celldex Therapeutics Antibody-drug Conjugate Products Offered
12.4.5 Celldex Therapeutics Recent Development
12.5 Synthon Holding BV
12.5.1 Synthon Holding BV Corporation Information
12.5.2 Synthon Holding BV Description and Business Overview
12.5.3 Synthon Holding BV Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Synthon Holding BV Antibody-drug Conjugate Products Offered
12.5.5 Synthon Holding BV Recent Development
12.11 Agensys
12.11.1 Agensys Corporation Information
12.11.2 Agensys Description and Business Overview
12.11.3 Agensys Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Agensys Antibody-drug Conjugate Products Offered
12.11.5 Agensys Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antibody-drug Conjugate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody-drug Conjugate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Antibody-drug Conjugate Market Segments
Table 2. Ranking of Global Top Antibody-drug Conjugate Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody-drug Conjugate Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Adcetris
Table 5. Major Manufacturers of Kadcyla
Table 6. Global Antibody-drug Conjugate Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Antibody-drug Conjugate Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Antibody-drug Conjugate Sales by Regions 2015-2020 (K Units)
Table 9. Global Antibody-drug Conjugate Sales Market Share by Regions (2015-2020)
Table 10. Global Antibody-drug Conjugate Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antibody-drug Conjugate Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Antibody-drug Conjugate Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Antibody-drug Conjugate Sales Share by Manufacturers (2015-2020)
Table 14. Global Antibody-drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Antibody-drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugate as of 2019)
Table 16. Antibody-drug Conjugate Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Antibody-drug Conjugate Price (2015-2020) (USD/Unit)
Table 19. Antibody-drug Conjugate Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Antibody-drug Conjugate Product Type
Table 21. Date of International Manufacturers Enter into Antibody-drug Conjugate Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody-drug Conjugate Sales by Type (2015-2020) (K Units)
Table 24. Global Antibody-drug Conjugate Sales Share by Type (2015-2020)
Table 25. Global Antibody-drug Conjugate Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Antibody-drug Conjugate Revenue Share by Type (2015-2020)
Table 27. Antibody-drug Conjugate Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Antibody-drug Conjugate Sales Share by Type (2021-2026)
Table 29. Global Antibody-drug Conjugate Sales by Application (2015-2020) (K Units)
Table 30. Global Antibody-drug Conjugate Sales Share by Application (2015-2020)
Table 31. Global Antibody-drug Conjugate Sales Share by Application (2021-2026)
Table 32. Global Antibody-drug Conjugate Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Antibody-drug Conjugate Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Antibody-drug Conjugate Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Antibody-drug Conjugate Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Antibody-drug Conjugate Sales Share by Company (2015-2020)
Table 37. Japan Antibody-drug Conjugate Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Antibody-drug Conjugate Sales (K Units) by Type (2015-2020)
Table 39. Japan Antibody-drug Conjugate Sales Share by Type (2015-2020)
Table 40. Japan Antibody-drug Conjugate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Antibody-drug Conjugate Price (K Units) by Type (2015-2020)
Table 42. Japan Antibody-drug Conjugate Sales (K Units) by Type (2021-2026)
Table 43. Japan Antibody-drug Conjugate Sales Share by Type (2021-2026)
Table 44. Japan Antibody-drug Conjugate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Antibody-drug Conjugate Revenue Share by Type (2021-2026)
Table 46. Japan Antibody-drug Conjugate Price (K Units) by Type (2021-2026)
Table 47. Japan Antibody-drug Conjugate Sales (K Units) by Application (2015-2020)
Table 48. Japan Antibody-drug Conjugate Sales Share by Application (2015-2020)
Table 49. Japan Antibody-drug Conjugate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Antibody-drug Conjugate Sales (K Units) by Application (2021-2026)
Table 51. Japan Antibody-drug Conjugate Sales Share by Application (2021-2026)
Table 52. Japan Antibody-drug Conjugate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Antibody-drug Conjugate Revenue Share by Application (2021-2026)
Table 54. North America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 55. North America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 56. North America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 58. Europe Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 59. Europe Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 60. Europe Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Antibody-drug Conjugate Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Antibody-drug Conjugate Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Table 66. Latin America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 67. Latin America Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Antibody-drug Conjugate Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2015-2020)
Table 74. Agensys Corporation Information
Table 75. Agensys Description and Business Overview
Table 76. Agensys Antibody-drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Agensys Antibody-drug Conjugate Product
Table 78. Agensys Recent Development
Table 79. Concortis Biotherapeutics Corporation Information
Table 80. Concortis Biotherapeutics Description and Business Overview
Table 81. Concortis Biotherapeutics Antibody-drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Concortis Biotherapeutics Product
Table 83. Concortis Biotherapeutics Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Business Overview
Table 86. Sanofi Antibody-drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Celldex Therapeutics Corporation Information
Table 90. Celldex Therapeutics Description and Business Overview
Table 91. Celldex Therapeutics Antibody-drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Celldex Therapeutics Product
Table 93. Celldex Therapeutics Recent Development
Table 94. Synthon Holding BV Corporation Information
Table 95. Synthon Holding BV Description and Business Overview
Table 96. Synthon Holding BV Antibody-drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Synthon Holding BV Product
Table 98. Synthon Holding BV Recent Development
Table 99. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 100. Key Challenges
Table 101. Market Risks
Table 102. Main Points Interviewed from Key Antibody-drug Conjugate Players
Table 103. Antibody-drug Conjugate Customers List
Table 104. Antibody-drug Conjugate Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugate Product Picture
Figure 2. Global Antibody-drug Conjugate Sales Market Share by Type in 2020 & 2026
Figure 3. Adcetris Product Picture
Figure 4. Kadcyla Product Picture
Figure 5. Global Antibody-drug Conjugate Sales Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Antibody-drug Conjugate Report Years Considered
Figure 9. Global Antibody-drug Conjugate Market Size 2015-2026 (US$ Million)
Figure 10. Global Antibody-drug Conjugate Sales 2015-2026 (K Units)
Figure 11. Global Antibody-drug Conjugate Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020)
Figure 13. Global Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 14. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020)
Figure 15. Global Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 16. Global Antibody-drug Conjugate Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Antibody-drug Conjugate Revenue in 2019
Figure 18. Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
Figure 20. Global Antibody-drug Conjugate Sales Market Share by Type in 2019
Figure 21. Global Antibody-drug Conjugate Revenue Market Share by Type (2015-2020)
Figure 22. Global Antibody-drug Conjugate Revenue Market Share by Type in 2019
Figure 23. Global Antibody-drug Conjugate Market Share by Price Range (2015-2020)
Figure 24. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
Figure 25. Global Antibody-drug Conjugate Sales Market Share by Application in 2019
Figure 26. Global Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
Figure 27. Global Antibody-drug Conjugate Revenue Market Share by Application in 2019
Figure 28. Japan Antibody-drug Conjugate Sales Growth Rate 2015-2026 (K Units)
Figure 29. Japan Antibody-drug Conjugate Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. Japan Antibody-drug Conjugate Market Share in Global Market 2015-2026
Figure 31. Japan 5 and 10 Largest Antibody-drug Conjugate Players Market Share by Revenue in Antibody-drug Conjugate in 2019
Figure 32. Japan Antibody-drug Conjugate Revenue Share by Type (2015-2020)
Figure 33. Japan Antibody-drug Conjugate Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Japan Antibody-drug Conjugate Revenue Share by Application (2015-2020)
Figure 35. Japan Antibody-drug Conjugate Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 39. North America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 40. U.S. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 47. Europe Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 48. Germany Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region in 2019
Figure 61. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region in 2019
Figure 62. China Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Latin America Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 87. Latin America Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 88. Mexico Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Middle East and Africa Antibody-drug Conjugate Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Antibody-drug Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country in 2019
Figure 98. Turkey Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Porter's Five Forces Analysis
Figure 105. Antibody-drug Conjugate Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
  • Global Cancer Treatment Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 133
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Chemotherapy - Targeted Therapy - Immunotherapy - Hormonal Therapy (Biologic Therapy) - Other......
  • Global DNA Repair Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - PARP Inhibitors - Other Segment by Application - Oncological - Stroke ......
  • Global Docetaxel Market Research Report 2021
    Published: 14-Jan-2021        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 20 mg/ml - 40 mg/ml - 60 mg/ml Segment by Application - Breast Cancer - Prosta......
  • Global Multiple Myeloma Drugs Market Research Report 2021
    Published: 14-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Chemotherapy - Corticosteroids - Immunomodulators - Monoclonal Antibodies - Histone Deacetyla......
  • Global Capecitabine Market Research Report 2021
    Published: 13-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 500 mg - 150 mg Segment by Application - Breast Cancer - Colorectal Cancer - S......
  • Global Xeloda Market Research Report 2021
    Published: 12-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 500 mg - 150 mg Segment by Application - Breast Cancer - Colorectal cancer - S......
  • Global Colorectal Cancer Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 05-Jan-2021        Price: US 3500 Onwards        Pages: 126
    Colorectal Cancer Drugs are drugs for the treatment of colorectal cancer. Based on the Colorectal Cancer Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics......
  • Global Erbitux Market Research Report 2021
    Published: 05-Jan-2021        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablet - Pill Segment by Application - Pregnant woman - Children - Aged ......
  • Global 5-fluorouracil Market Research Report 2021
    Published: 04-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Injectables - Capsules - Tablets Segment by Application - Colon and Rectal Cancer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs